col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Association for the Advancement of Science (AAAS): Science Advances
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―14 Meaningful messaging: Sentiment in elite social media communication with the public on the COVID-19 pandemic Janet M. Box-Steffensmeier, Laura Moses
2 [GO] 2021―Jul―02 Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine Dong An, Kun Li, Dawne K. Rowe, Maria Cristina Huertas Diaz, Emily F. Griffin, Ashley C. Beavis, et al. (+14)
3 [GO] 2021―Jun―30 Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies Namshik Han, Woochang Hwang, Konstantinos Tzelepis, Patrick Schmerer, Eliza Yankova, Méabh MacMahon, et al. (+10)
4 [GO] 2021―Jun―25 Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test Jacob T. Heggestad, David S. Kinnamon, Lyra B. Olson, Jason Liu, Garrett Kelly, Simone A. Wall, et al. (+18)
5 [GO] 2021―Jun―23 Effects of COVID-19 lockdowns on fine particulate matter concentrations Melanie S. Hammer, Aaron van Donkelaar, Randall V. Martin, Erin E. McDuffie, Alexei Lyapustin, Andrew M. Sayer, et al. (+5)
6 [GO] 2021―Jun―16 Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity Hin Chu, Huiping Shuai, Yuxin Hou, Xi Zhang, Lei Wen, Xiner Huang, et al. (+19)
7 [GO] 2021―Jun―09 Global tropospheric ozone responses to reduced NOx emissions linked to the COVID-19 worldwide lockdowns Kazuyuki Miyazaki, Kevin Bowman, Takashi Sekiya, Masayuki Takigawa, Jessica L. Neu, Kengo Sudo, et al. (+2)
8 [GO] 2021―May―28 Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates So-Hee Hong, Hanseul Oh, Yong Wook Park, Hye Won Kwak, Eun Young Oh, Hyo-Jung Park, et al. (+30)
9 [GO] 2021―May―26 Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses Sham Nambulli, Yufei Xiang, Natasha L. Tilston-Lunel, Linda J. Rennick, Zhe Sang, William B. Klimstra, et al. (+4)
10 [GO] 2021―May―26 Lessons from a pandemic for systems-oriented sustainability research Noelle E. Selin
11 [GO] 2021―May―21 Air pollution impacts of COVID-19-related containment measures Guillaume P. Chossière, Haofeng Xu, Yash Dixit, Stewart Isaacs, Sebastian D. Eastham, Florian Allroggen, et al. (+2)
12 [GO] 2021―May―12 Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients Hyoyoung Jeong, Jong Yoon Lee, KunHyuck Lee, Youn J. Kang, Jin-Tae Kim, Raudel Avila, et al. (+25)
13 [GO] 2021―May―07 The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China Juanjuan Zhang, Maria Litvinova, Yuxia Liang, Wen Zheng, Huilin Shi, Alessandro Vespignani, et al. (+3)
14 [GO] 2021―May―06 Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11 Juliette Fedry, Daniel L. Hurdiss, Chunyan Wang, Wentao Li, Gonzalo Obal, Ieva Drulyte, et al. (+5)
15 [GO] 2021―Apr―23 SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity Annachiara Rosa, Valerie E. Pye, Carl Graham, Luke Muir, Jeffrey Seow, Kevin W. Ng, et al. (+34)
16 [GO] 2021―Apr―16 The SARS-CoV-2 Spike variant D614G favors an open conformational state Rachael A. Mansbach, Srirupa Chakraborty, Kien Nguyen, David C. Montefiori, Bette Korber, S. Gnanakaran
17 [GO] 2021―Apr―14 Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking Marion Schuller, Galen J. Correy, Stefan Gahbauer, Daren Fearon, Taiasean Wu, Roberto Efraín Díaz, et al. (+47)
18 [GO] 2021―Mar―19 Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app Carole H. Sudre, Karla A. Lee, Mary Ni Lochlainn, Thomas Varsavsky, Benjamin Murray, Mark S. Graham, et al. (+27)
19 [GO] 2021―Mar―19 Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates Linling He, Xiaohe Lin, Ying Wang, Ciril Abraham, Cindy Sou, Timothy Ngo, et al. (+3)
20 [GO] 2021―Mar―17 Catalytic amplification by transition-state molecular switches for direct and sensitive detection of SARS-CoV-2 Noah R. Sundah, Auginia Natalia, Yu Liu, Nicholas R. Y. Ho, Haitao Zhao, Yuan Chen, et al. (+8)
21 [GO] 2021―Mar―05 An early warning approach to monitor COVID-19 activity with multiple digital traces in near real time Nicole E. Kogan, Leonardo Clemente, Parker Liautaud, Justin Kaashoek, Nicholas B. Link, Andre T. Nguyen, et al. (+11)
22 [GO] 2021―Mar―05 Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution Supriya Ravichandran, Youri Lee, Gabrielle Grubbs, Elizabeth M. Coyle, Laura Klenow, Osamu Akasaka, et al. (+17)
23 [GO] 2021―Feb―24 Supporting women in academia during and after a global pandemic Tiffany A. Reese, Tamia A. Harris-Tryon, Jennifer G. Gill, Laura A. Banaszynski
24 [GO] 2021―Feb―22 Immunogenicity of clinically relevant SARS-CoV-2 vaccines in non-human primates and humans P. J. Klasse, Douglas F. Nixon, John P. Moore
25 [GO] 2021―Feb―17 An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants Kui K. Chan, Timothy J. C. Tan, Krishna K. Narayanan, Erik Procko
26 [GO] 2021―Feb―14 INSIGHT: A population-scale COVID-19 testing strategy combining point-of-care diagnosis with centralized high-throughput sequencing Qianxin Wu, Chenqu Suo, Tom Brown, Tengyao Wang, Sarah A. Teichmann, Andrew R. Bassett
27 [GO] 2021―Feb―14 Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile Carolina Beltrán-Pavez, Sebastián Riquelme-Barrios, Aarón Oyarzún-Arrau, Aracelly Gaete-Argel, Roxana González-Stegmaier, Karina Cereceda-Solis, et al. (+14)
28 [GO] 2021―Feb―09 A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2 Martin P. Steinbuck, Lochana M. Seenappa, Aniela Jakubowski, Lisa K. McNeil, Christopher M. Haqq, Peter C. DeMuth
29 [GO] 2021―Feb―09 Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression Ke Zhang, Lisa Miorin, Tadashi Makio, Ishmael Dehghan, Shengyan Gao, Yihu Xie, et al. (+13)
30 [GO] 2021―Feb―08 Falling living standards during the COVID-19 crisis: Quantitative evidence from nine developing countries Dennis Egger, Edward Miguel, Shana S. Warren, Ashish Shenoy, Elliott Collins, Dean Karlan, et al. (+20)
31 [GO] 2021―Feb―03 Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19 Sascha Jung, Ilya Potapov, Samyukta Chillara, Antonio del Sol
32 [GO] 2021―Feb―03 A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood Dianna L. Ng, Andrea C. Granados, Yale A. Santos, Venice Servellita, Gregory M. Goldgof, Cem Meydan, et al. (+26)
33 [GO] 2021―Feb―03 Vaccine optimization for COVID-19: Who to vaccinate first? Laura Matrajt, Julia Eaton, Tiffany Leung, Elizabeth R. Brown
34 [GO] 2021―Jan―13 Abrupt but smaller than expected changes in surface air quality attributable to COVID-19 lockdowns Zongbo Shi, Congbo Song, Bowen Liu, Gongda Lu, Jingsha Xu, Tuan Van Vu, et al. (+4)
35 [GO] 2021―Jan―08 A smartphone-read ultrasensitive and quantitative saliva test for COVID-19 Bo Ning, Tao Yu, Shengwei Zhang, Zhen Huang, Di Tian, Zhen Lin, et al. (+11)
36 [GO] 2021―Jan―06 Partisan pandemic: How partisanship and public health concerns affect individuals’ social mobility during COVID-19 J. Clinton, J. Cohen, J. Lapinski, M. Trussler
37 [GO] 2021―Jan―01 Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening Daniel B. Larremore, Bryan Wilder, Evan Lester, Soraya Shehata, James M. Burke, James A. Hay, et al. (+3)
38 [GO] 2020―Dec―09 Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, Aisha Souquette, Daniel Reynolds, Diane Bender, et al. (+13)
39 [GO] 2020―Dec―05 Differential effects of intervention timing on COVID-19 spread in the United States Sen Pei, Sasikiran Kandula, Jeffrey Shaman
40 [GO] 2020―Dec―05 Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM Cong Xu, Yanxing Wang, Caixuan Liu, Chao Zhang, Wenyu Han, Xiaoyu Hong, et al. (+13)
41 [GO] 2020―Dec―03 Satellite-based estimates of decline and rebound in China’s CO2 emissions during COVID-19 pandemic Bo Zheng, Guannan Geng, Philippe Ciais, Steven J. Davis, Randall V. Martin, Jun Meng, et al. (+10)
42 [GO] 2020―Nov―21 Damaged lung gas-exchange function of discharged COVID-19 patients detected by hyperpolarized 129Xe MRI Haidong Li, Xiuchao Zhao, Yujin Wang, Xin Lou, Shizhen Chen, He Deng, et al. (+7)
43 [GO] 2020―Nov―19 Social connections with COVID-19-affected areas increase compliance with mobility restrictions Ben Charoenwong, Alan Kwan, Vesa Pursiainen
44 [GO] 2020―Nov―14 JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality Justin Stebbing, Ginés Sánchez Nievas, Marco Falcone, Sonia Youhanna, Peter Richardson, Silvia Ottaviani, et al. (+44)
45 [GO] 2020―Nov―07 Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L Michael Dominic Sacco, Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia Alma Townsend, Xiangzhi Meng, et al. (+11)
46 [GO] 2020―Nov―05 Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis X. Wu, R. C. Nethery, M. B. Sabath, D. Braun, F. Dominici
47 [GO] 2020―Nov―05 How air pollution may influence the course of pandemics Jeremy Jackson, Kip Hodges
48 [GO] 2020―Oct―30 Fatalities from COVID-19 are reducing Americans’ support for Republicans at every level of federal office Christopher Warshaw, Lynn Vavreck, Ryan Baxter-King
49 [GO] 2020―Oct―23 Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response Ashish Goyal, E. Fabian Cardozo-Ojeda, Joshua T. Schiffer
50 [GO] 2020―Oct―16 Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, Stephanie Patchett, Digant Nayak, Scott J. Snipas, et al. (+5)
51 [GO] 2020―Oct―09 Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals Yuanmei Zhu, Danwei Yu, Yang Han, Hongxia Yan, Huihui Chong, Lili Ren, et al. (+3)
52 [GO] 2020―Sep―25 Model uncertainty, political contestation, and public trust in science: Evidence from the COVID-19 pandemic S.E. Kreps, D. L. Kriner
53 [GO] 2020―Sep―23 The unfolding COVID-19 pandemic: A probability-based, nationally representative study of mental health in the U.S. E. Alison Holman, Rebecca R. Thompson, Dana Rose Garfin, Roxane Cohen Silver
54 [GO] 2020―Sep―18 Antibody-like proteins that capture and neutralize SARS-CoV-2 T. Kondo, Y. Iwatani, K. Matsuoka, T. Fujino, S. Umemoto, Y. Yokomaku, et al. (+5)
55 [GO] 2020―Sep―16 Reimagining scientific conferences during the pandemic and beyond Thale Jarvis, Shannon Weiman, Deborah Johnson
56 [GO] 2020―Sep―11 Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease Cintia A. Menéndez, Fabian Byléhn, Gustavo R. Perez-Lemus, Walter Alvarado, Juan J. de Pablo
57 [GO] 2020―Sep―02 Continuous on-body sensing for the COVID-19 pandemic: Gaps and opportunities Hyoyoung Jeong, John A. Rogers, Shuai Xu
58 [GO] 2020―Aug―21 Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers Noam Shental, Shlomia Levy, Vered Wuvshet, Shosh Skorniakov, Bar Shalem, Aner Ottolenghi, et al. (+12)
59 [GO] 2020―Aug―14 Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study Jing Qin, Chong You, Qiushi Lin, Taojun Hu, Shicheng Yu, Xiao-Hua Zhou
60 [GO] 2020―Aug―05 Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19 Martha K. Berg, Qinggang Yu, Cristina E. Salvador, Irene Melani, Shinobu Kitayama
61 [GO] 2020―Jul―31 Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia Hee Ho Park, Hong Nam Kim, Hyelim Kim, Youngbum Yoo, Hyosoo Shin, Eun Young Choi, et al. (+2)
62 [GO] 2020―Jul―24 Non-neuronal expression of SARS-CoV-2 entry genes in the olfaory system suggests mechanisms underlying COVID-19-associated anosmia David H. Brann, Tatsuya Tsukahara, Caleb Weinreb, Marcela Lipovsek, Koen Van den Berge, Boying Gong, et al. (+19)
63 [GO] 2020―Jul―17 Cancer did not stay home for COVID-19 Ross L. Levine
64 [GO] 2020―Jun―24 Elusive consensus: Polarization in elite communication on the COVID-19 pandemic Jon Green, Jared Edgerton, Daniel Naftel, Kelsey Shoub, Skyler J. Cranmer
65 [GO] 2020―Jun―24 Structure-based drug designing and immunoinformatics approach for SARS-CoV-2 Pritam K. Panda, Murugan N. Arul, Paritosh Patel, Suresh K. Verma, Wei Luo, Horst-Günter Rubahn, et al. (+3)
66 [GO] 2020―Jun―12 Abrupt decline in tropospheric nitrogen dioxide over China after the outbreak of COVID-19 Fei Liu, Aaron Page, Sarah A. Strode, Yasuko Yoshida, Sungyeon Choi, Bo Zheng, et al. (+9)
67 [GO] 2020―Jun―12 Pandemics and the global environment Kip Hodges, Jeremy Jackson
68 [GO] 2020―Jun―05 Medical education in the time of COVID-19 Diane B. Wayne, Marianne Green, Eric G. Neilson
69 [GO] 2020―May―29 COVID-19 and the next influenza season Benjamin D. Singer
70 [GO] 2020―May―29 Emergence of SARS-CoV-2 through recombination and strong purifying selection Xiaojun Li, Elena E. Giorgi, Manukumar Honnayakanahalli Marichannegowda, Brian Foley, Chuan Xiao, Xiang-Peng Kong, et al. (+4)
71 [GO] 2020―May―22 SARS-CoV2 vaccines: Slow is fast Douglas R. Green
72 [GO] 2020―May―22 SARS-CoV2 vaccines: Slow is fast Douglas R. Green
73 [GO] 2020―May―18 Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2 Salvatore Di Giorgio, Filippo Martignano, Maria Gabriella Torcia, Giorgio Mattiuz, Silvestro G. Conticello
74 [GO] 2020―May―11 COVID-19: Rescue by transcriptional inhibition Ali Shilatifard
75 [GO] 2020―May―07 Point of no return: COVID-19 and the US health care systemAn emergency physician’s perspective Maia Dorsett
76 [GO] 2020―Apr―27 Mobile phone data for informing public health actions across the COVID-19 pandemic life cycle Nuria Oliver, Bruno Lepri, Harald Sterly, Renaud Lambiotte, Sébastien Delataille, Marco De Nadai, et al. (+18)
77 [GO] 2020―Apr―17 Surviving COVID-19: A disease tolerance perspective Janelle S. Ayres


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec